{
    "Trade/Device Name(s)": [
        "AssureTech Panel Dip Tests",
        "AssureTech Quick Cup Tests"
    ],
    "Submitter Information": "Assure Tech. Co., Ltd.",
    "510(k) Number": "K181768",
    "Predicate Device Reference 510(k) Number(s)": [
        "K122809"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NFT",
        "NFY",
        "NGG",
        "NFW",
        "NGL",
        "NFV",
        "PTH",
        "NGM",
        "PTG",
        "QAW",
        "QBF"
    ],
    "Summary Letter Date": "August 20, 2018",
    "Summary Letter Received Date": "July 19, 2018",
    "Submission Date": "June 29, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3870",
        "21 CFR 862.3250",
        "21 CFR 862.3610",
        "21 CFR 862.3650",
        "21 CFR 862.3170",
        "21 CFR 862.3150",
        "21 CFR 862.3620",
        "21 CFR 862.3910",
        "21 CFR 862.3700"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system",
        "Cannabinoids test system",
        "Cocaine and cocaine metabolites test system",
        "Methamphetamine test system",
        "Morphine test system",
        "Benzodiazepine test system",
        "Barbiturate test system",
        "Methadone test system",
        "Tricyclic antidepressant drugs test system",
        "Propoxyphene test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Oxazepam",
        "Cocaine",
        "Marijuana",
        "Methamphetamine",
        "Morphine",
        "Oxycodone",
        "Secobarbital",
        "Buprenorphine",
        "Methylenedioxy-methamphetamine",
        "Phencyclidine",
        "Methadone",
        "EDDP",
        "Nortriptyline",
        "d-Propoxyphene"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Urine cup"
    ],
    "Instrument(s)/Platform(s)": [
        "Panel Dip Card",
        "Cup"
    ],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunochromatographic assay",
        "Competitive binding immunoassay"
    ],
    "Methodologies": [
        "Immunochemistry",
        "Lateral flow assay"
    ],
    "Submission Type(s)": [
        "Test",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for AssureTech Panel Dip Tests and AssureTech Quick Cup Tests for qualitative detection of multiple drugs of abuse in human urine using lateral flow immunochromatographic assay.",
    "Indications for Use Summary": "Qualitative, simultaneous detection of Amphetamine, Oxazepam, Cocaine, Marijuana, Methamphetamine, Morphine, Oxycodone, Secobarbital, Buprenorphine, Methylenedioxy-methamphetamine, Phencyclidine, Methadone, EDDP, Nortriptyline, and d-Propoxyphene in human urine at specified cutoffs; provides preliminary results, for in vitro diagnostic use only.",
    "fda_folder": "Toxicology"
}